Debiopharm Innovation Fund has announced the inclusion of StratifAI in its growing portfolio. Known for its investments in innovative healthcare technologies, Debiopharm aims to leverage StratifAI’s advanced artificial intelligence capabilities to enhance its venture objectives. This addition not only strengthens Debiopharm’s portfolio but also signals a commitment to advanced healthcare solutions.
Healthcare Technology, Artificial Intelligence,Global, Switzerland
https://www.debiopharm.com/debiopharm-innovation-fund-welcomes-stratifai-to-their-portfolio/